C. Cruz

Fluoxetine shows modest antiviral effects against COVID-19 but is not a primary treatment option.

A review reveals the need for better clinical trial reporting in the Nordic region.

ANDES improves gene set comparisons for better biological insights.

New studies suggest shorter treatments for Chagas disease may be effective.